Clinical Trials Browser

Phase 1 × OTHER × Respiratory Distress Syndrome × Clear all

NCT02804945 2020-04-10

Mesenchymal Stem Cells (MSCs) for Treatment of Acute Respiratory Distress Syndrome (ARD) in Patients With Malignancies

Phase 1 Completed

Respiratory Distress Syndrome